NCT06957613

Brief Summary

A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
81mo left

Started Jul 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jul 2017Dec 2032

Study Start

First participant enrolled

July 1, 2017

Completed
7.8 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

May 4, 2025

Status Verified

April 1, 2025

Enrollment Period

13.5 years

First QC Date

April 26, 2025

Last Update Submit

May 2, 2025

Conditions

Keywords

Chronic Total Occlusion

Outcome Measures

Primary Outcomes (1)

  • Rate of in-hospital and long-term cardiovascular adverse events in percent

    Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death)

    2 years

Study Arms (1)

Patients with Coronary Chronic Total Occlusions

Patients undergoing Recanalization for Coronary Chronic Total Occlusions

Procedure: Revascularization/Conservative management

Interventions

Percutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.

Patients with Coronary Chronic Total Occlusions

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with coronary chronic total occlusions undergoing recanalization vie percutaneous coronary interventions

You may qualify if:

  • Patients with coronary chronic total occlusions undergoing recanalization via percutaneous coronary interventions

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Herzzentrum Segeberger Kliniken GmbH

Bad Segeberg, Schleswig-Holstein, 23795, Germany

RECRUITING

MeSH Terms

Interventions

Conservative Treatment

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Holger Nef, Prof., MD

    Herzzentrum Segeberger Kliniken GmbH

    STUDY DIRECTOR

Central Study Contacts

Nader Mankerious, MD

CONTACT

Stephan Fichtlscherer, Prof., MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2025

First Posted

May 4, 2025

Study Start

July 1, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2032

Last Updated

May 4, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations